ResearcherNantong UniversityNo recent work listed

Yan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1378-1825; OpenAlex author ID A5100351050. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper

Papers 1

Retraction Note to: S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway. Co-author DOI 10.1007/s00210-021-02126-x ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lei Qin · 1 shared paper, 2021 · strength 0.16
- Paper Retraction Note to: S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreati… DOI 10.1007/s00210-021-02126-x ↗
Linxun Liu · 1 shared paper, 2021 · strength 0.16
- Paper Retraction Note to: S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreati… DOI 10.1007/s00210-021-02126-x ↗
Genhai Shen · 1 shared paper, 2021 · strength 0.16
- Paper Retraction Note to: S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreati… DOI 10.1007/s00210-021-02126-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.